Abstract
Clinical manifestations in children living with HIV/ AIDS differ from those in adults due to poorly developed immunity that allows greater dissemination throughout various organs. In developing countries, HIV-infected children have an increased frequency of malnutrition and common childhood infections such as ear infections, pneumonias, gastroenteritis and tuberculosis. The symptoms common to many treatable conditions, such as recurrent fever, diarrhea and generalized dermatitis, tend to be more persistent and severe and often do not respond as well to treatment. The use of Anti Retroviral Therapy (ART) has greatly increased the long term survival of perinatally infected children so that AIDS is becoming a manageable chronic illness. As the immunity is maintained, the incidence of infectious complications is declining while noninfectious complications of HIV are more frequently encountered. Regular clinical monitoring with immunological and virological monitoring and the introduction of genotypic and phenotypic resistance testing where resources are available have allowed for dramatically better clinical outcomes. However, these growing children are left facing the challenges of lifelong adherence with complex treatment regimens, compounded by complex psycho-social, mental and neuro-cognitive issues. These unique challenges must be recognized and understood in order to provide appropriate medical management.
Similar content being viewed by others
References
NACO Annual Report 2010–11. Available from http://www.nacoonline.org/Quick_Links/HIV_Data/. Accessed on 13th August 2011.
Behrman RE, Kleigman RM, Jenson HB. Nelson textbook of pediatrics. 18th ed. Philadelphia: W.B. Saunders company; 2007.
Center for Disease Control. Human immunodeficiency virus infection codes and official guidelines for coding and reporting ICD-9-CM. MMWR Recomm Rep. 1994;43(RR- 12):1–19.
WHO. WHO Case Definitions of HIV for Surveillance and Revised Clinical Staging and Immunological Classification of HIV-related disease in Adults and Children, August 7, 2006.
Merchant RH, Oswal JS, Bhagwat RV, Karkare J. Clinical profile of HIV infection. Indian Pediatr. 2001;38:239–46.
Abuzaitoun OR, Hanson IC. Organ-specific manifestations of HIV disease in children. Pediatr Clin North Am. 2000;47:109–25.
Majaliwa ES, Mohn A, Chiarelli F. Growth and puberty in children with HIV infection. J Endocrinol Invest. 2009;32:85–90.
Majaliwa ES, Chiavaroli V, Mohn A, Chiarelli F. Growth / Development / Puberty in HIV-infected Children and Disorders of the Same. In: Lala MM, Merchant RH, eds. Principles of perinatal and pediatric HIV/AIDS. India: Jaypee Brothers Medical Publishers (P) Ltd; 2011. pp 196–211.
Serwadda D, Mugerwa RD, Sewankambo NK, et al. Slim disease: a new disease in Uganda and its association with HTLV-III Infection. Lancet. 1985;2:849–52.
Shah SR, Tullu MS, Kamat JR. Clinical profile of pediatric HIV infection from India. Arch Med Res. 2005;36:24–31.
Chandra RK, Kumari S. Nutrition and immunity: an overview. J Nutr. 1994;124:1433S–5S.
WHO. Guidelines for an Integrated Approach to the Nutritional Care of HIV Infected children (6 mo to 14 y). In: Rollins N, ed. Preliminary version for country introduction. Handbook. Geneva: WHO Library Catalogue in Publication Data; 2009.
Kotler DP. “The effects of growth hormone therapy in HIV-infection”. Am J Infect Dis. FindArticles.com. 17 Aug, 2011. Available from http://findarticles.com/p/articles/mi_6891/is_3_2/ai_n28394801/. Accessed on 16th August 2011.
Mosam A, Mankahla A. Identification and Management of Cutaneous Manifestations of HIV in Adults and Children. In: Marlink RG, Teitelman SJ, editors. From the Ground Up: Building Comprehensive HIV/AIDS Care Programmes in Resource-Limited Settings. Washington: The Elizabeth Glaser Pediatric AIDS Foundation; 2009.
Marolda J, Pace B, Bonforte RJ, Kotin NM, Rabinowitz J, Kattan M. Pulmonary manifestations of HIV infection in children. Pediatr Pulmonol. 1991;10:231–5.
Vargas SL, Hughes WT, Santolaya ME, et al. Search for primary infection by Pneumocystis carinii in a cohort of normal, healthy infants. Clin Infect Dis. 2001;32:855–61.
National AIDS Control Organization. Guidelines for HIV care and Treatment in infants and children: 2006. Available from http://www.nacoonline.org/NACO/. Accessed on August 11th 2011.
Marais BJ. Tuberculosis in children. Pediatr Pulmonol. 2008;43:322–9.
Lala MM. HIV related Lung Diseases in Children. In: Arora VK, ed. Manual on Tuberculosis, HIV and Lung Diseases: A Practical Approach. India: Jaypee Brothers Medical Publishers; 2009. pp. 320–35.
Moulignier A. HIV and the central nervous system. Rev Neurol (Paris). 2006;162:22–42.
Exhenry C, Nadal D. Vertical human immunodeficiency virus-1 infection: involvement of the central nervous system and treatment. Eur J Pediatr. 1996;155:839–50.
NIH, Centers for Disease Control and Prevention, and the HIV Medicine Association of the Infectious Diseases Society of America. Guidelines for the prevention and treatment of opportunistic infections among HIV-exposed and HIV-infected children-Progressive multifocal leucoencephalopathy. [online]. [cited 2009 sept 4]; Available from: http://www.aidsinfo.nih.gov. Accessed on August 11th 2011.
Lugassy DM, Farmer BM, Nelson LS. Metabolic and hepatobiliary side effects of antiretroviral therapy (ART). Emerg Med Clin North Am. 2010;28:409–19.
Barbaro G. Cardiovascular manifestation of HIV infection. J R Soc Med. 2001;94:384–90.
Gherardi R, Belec L, Mhiri C, et al. The spectrum of vasculitis in human immunodeficiency virus- infected patients. A clinicopathologic evaluation. Arthritis Rheum. 1993;36:1164–74.
Taylor P, Worrell C, Steinberg SM, et al. Natural history of lipid abnormalities and fat redistribution among human immunodeficiency virus-infected children receiving long-term, protease inhibitor-containing, highly active antiretroviral therapy regimens. Pediatrics. 2004;114:e235–42.
Barbaro G. Cardiac involvement in the acquired immunodeficiency syndrome. AIDS Res Hum Retroviruses. 1998;14:1071–7.
Rao TKS, Friedman EA, Nicastri AD. The types of renal disease in the acquired immunodeficiency syndrome. N Engl J Med. 1987;316:1062–68.
Bhimma R. HIV and Renal Disease in Children. HIV in Children [serial online] 2007 [cited 2007 October 15]1;1. Available from: http://www.hivinchildren.org/Treatment_issues/hiv_renaldisease.asp. Accessed on August 11th 2011.
Steel-Duncan J, Miller M, Pierre RB, et al. Kingston Paediatric and Perinatal HIV/ AIDS Study Group. Renal manifestations in HIV-infected Jamaican children. West Indian Med J. 2008;57:246.
Izzedine H, Harris M, Perazella MA. The nephrotoxic effects of HAART. Nat Rev Nephrol. 2009;5:563–73.
Calis JC, van Hensbroek MB, de Haan RJ, Moons P, Brabin BJ, Bates I. HIV-associated anemia in children: a systematic review from a global perspective. AIDS. 2008;22:1099–112.
Conflict of Interest
None.
Role of Funding Source
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Merchant, R.H., Lala, M.M. Common Clinical Problems in Children Living with HIV/AIDS: Systemic Approach. Indian J Pediatr 79, 1506–1513 (2012). https://doi.org/10.1007/s12098-012-0865-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12098-012-0865-y